Anemia Clinical Trial
Official title:
Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX
- In approx. 40% of the incidences anemia is caused by iron deficiency (= ID). In turn,
preoperative iron-deficiency anemia (= IDA) is associated with an increase in morbidity
and mortality as well as with the need for a blood transfusion.
- A successful preoperative treatment of IDA via iron supplementation requires a timely
screening of iron deficiency, typically done by analyzing specific blood parameters.
This however of course requires drawing a blood sample which further reduces the
patients' blood volume and is in many cases stated as an inconvenient procedure.
- Measured in blood zinc protoporphyrin-IX (= ZnPP) is an established parameter to detect
ID.
- This study aims to evaluate a prototype device detecting ZnPP non-invasively in the
intact oral mucosa of surgical patients.
- Results from the non-invasive measurement will be compared to reference measurements of
ZnPP from residual blood samples (HPLC analysis) as well as to other parameters
including Hb level and iron profile (MCH [= mean corpuscular hemoglobin], MCV [= mean
corpuscular volume], ferritin, transferrin, transferrin saturation, soluble transferrin
receptor, CRP).
The non-invasive measurements will be performed using a prototype device based on
fluorescence spectroscopical techniques. In brief, light (restricted wavelengths: 407 /
425nm) will be used to excite ZnPP molecules within the blood of the oral mucosa by means of
an optical fibre prob. The outgoing fluorescence emission of the excited molecules will be
analyzed using a spectrometer and converted to a ZnPP value [unit: µmol/mol heme] using
mathematical transformations as well as spectral fitting.
This study compares the diagnostic performance of iron deficiency based on non-invasive
measurements of Zinc protoporphyrin with results based on standard laboratory procedure (i.e.
ZnPP measured in whole blood sample using HPLC) and blood values assessed during clinical
routine, respectively.
If results of non-invasive and reference measurement techniques yield coinciding results, the
non-invasive method could provide an improved mean to detect iron deficiency and thereby to
improve treatment of patients suffering from iron deficiency anemia.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |